share_log

Why Asymchem Laboratories (Tianjin)'s (SZSE:002821) Shaky Earnings Are Just The Beginning Of Its Problems

Why Asymchem Laboratories (Tianjin)'s (SZSE:002821) Shaky Earnings Are Just The Beginning Of Its Problems

凱萊英(天津)(SZSE:002821)的利潤不穩定只是問題的開始
Simply Wall St ·  11/05 18:08

Investors were disappointed by Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821 ) latest earnings release. Our analysis has found some reasons to be concerned, beyond the weak headline numbers.

投資者對凱萊英(臨時代碼)最新的營業收入發佈感到失望。我們的分析發現一些令人擔憂的原因,超越了弱劣的頭條數字。

big
SZSE:002821 Earnings and Revenue History November 5th 2024
SZSE:002821 收益和營業收入歷史 2024年11月5日

How Do Unusual Items Influence Profit?

非常規項目如何影響利潤?

Importantly, our data indicates that Asymchem Laboratories (Tianjin)'s profit received a boost of CN¥56m in unusual items, over the last year. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And that's as you'd expect, given these boosts are described as 'unusual'. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

重要的是,我們的數據顯示,凱萊英(臨時代碼)的利潤在過去一年中由飛凡項目提振了5,600萬元人民幣。儘管利潤增加總是令人高興的,但飛凡項目的大額貢獻有時會抑制我們的熱情。我們對全球大多數公開上市公司進行了數據分析,發現飛凡項目往往是一次性的。這是可以預料的,因爲這些提振被描述爲「飛凡」。假設這些飛凡項目不會再次出現在當前年度,那麼我們預計明年的利潤將更加疲軟(在沒有業務增長的情況下)。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓您想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看基於其估計的未來盈利能力的互動圖表。

Our Take On Asymchem Laboratories (Tianjin)'s Profit Performance

我們對凱萊英(臨時代碼)的利潤表現的看法

We'd posit that Asymchem Laboratories (Tianjin)'s statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Therefore, it seems possible to us that Asymchem Laboratories (Tianjin)'s true underlying earnings power is actually less than its statutory profit. In further bad news, its earnings per share decreased in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you'd like to know more about Asymchem Laboratories (Tianjin) as a business, it's important to be aware of any risks it's facing. Case in point: We've spotted 2 warning signs for Asymchem Laboratories (Tianjin) you should be aware of.

我們認爲凱萊英(臨時代碼)的法定收益並不完全反映其持續生產力,因爲存在大額飛凡項目。因此,對我們而言,凱萊英(臨時代碼)真正的基本盈利能力實際上可能低於其法定利潤。更糟糕的是,其每股收益在過去一年有所下降。當然,在分析其收益方面時,我們只是觸及表面;人們還可以考慮利潤率、預測增長和投資回報率等其他因素。如果您想更多地了解凱萊英(臨時代碼)作爲一個業務,重要的是要意識到它面臨的任何風險。舉個例子:我們發現了凱萊英(臨時代碼)2個需要注意的預警信號。

Today we've zoomed in on a single data point to better understand the nature of Asymchem Laboratories (Tianjin)'s profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

今天,我們聚焦在一個數據點上,以更好地理解凱萊英(臨時代碼)利潤的性質。但如果您能夠專注於細節,總會有更多發現。有些人認爲股本回報率高是一個優質企業的好跡象。儘管這可能需要您進行一些研究,您可能會發現這個免費公司收藏具有高股本回報率,或者這個具有大量內部持股的股票清單是有用的。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論